Read More General business news FDA approves Novartis’ Cosentyx for hidradenitis suppurativa treatment Novartis, a global leader in immuno-dermatology and rheumatology, announced the U.S. Food and Drug Administration’s approval of Cosentyx… byPallavi MadhirajuNovember 1, 2023